# Medtronic scraps plans to buy EOFlow

Medtronic called off its planned acquisition of EOFlow, a maker of insulin patch-pumps, citing multiple breaches of agreements. The deal was valued at about $738 million.

- Type: Acquisition
- Announced: 2023-12-07
- Value: $738.0M
- Status: cancelled
- Products: insulin patch-pump
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Medtronic plc](https://endata.com/companies/19071.md) (acquirer)
- [EOFlow](https://endata.com/companies/55385.md) (target)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/medtronic-eoflow-acquisition-canceled-insulin-patch/701841/), 2023-12-07: "Medtronic called off its plans to buy EOFlow, a company making an insulin patch-pump that is embroiled in a patent dispute with Insulet, Medtronic said in a Wednesday filing with the U.S. Securities and Exchange Commission."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.